YUSAC2 (Q54995793)

From Wikidata

Jump to navigation Jump to search

cell line

YUSAC-2
YUSAC 2
YUSAC

Language	Label	Description	Also known as
English	YUSAC2	cell line	YUSAC-2 YUSAC 2 YUSAC

Statements

1 reference

Cellosaurus release 49

15 July 2024

cancer cell line

1 reference

Cellosaurus release 49

15 July 2024

described by source

Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells

1 reference

Cellosaurus release 49

15 July 2024

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

1 reference

Cellosaurus release 49

15 July 2024

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies

1 reference

Cellosaurus release 49

15 July 2024

Integrated analysis of tumor samples sheds light on tumor heterogeneity

1 reference

Cellosaurus release 49

15 July 2024

established from medical condition

1 reference

Cellosaurus release 49

15 July 2024

derived from organism type

1 reference

Cellosaurus release 49

15 July 2024

Identifiers

1 reference

Cellosaurus release 49

15 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54995793&oldid=2258597125"